Entera Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Entera Bio and other ETFs, options, and stocks.About ENTX
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2.
CEOMiranda J. Toledano
CEOMiranda J. Toledano
Employees20
Employees20
HeadquartersJerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded2009
Founded2009
Employees20
Employees20
ENTX Key Statistics
Market cap58.24M
Market cap58.24M
Price-Earnings ratio-5.19
Price-Earnings ratio-5.19
Dividend yield—
Dividend yield—
Average volume130.36K
Average volume130.36K
High today$1.37
High today$1.37
Low today$1.26
Low today$1.26
Open price$1.35
Open price$1.35
Volume51.29K
Volume51.29K
52 Week high$3.22
52 Week high$3.22
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
As of today, Entera Bio(ENTX) shares are valued at $1.27. The company's market cap stands at 58.24M, with a P/E ratio of -5.19.
During the trading session on 2026-03-15, Entera Bio(ENTX) shares reached a daily high of $1.37 and a low of $1.26. At a current price of $1.27, the stock is +0.8% higher than the low and still -7.2% under the high.
Trading volume for Entera Bio(ENTX) stock has reached 51.29K, versus its average volume of 130.36K.
Over the past 52 weeks, Entera Bio(ENTX) stock has traded between a high of $3.22 and a low of $1.00.
Over the past 52 weeks, Entera Bio(ENTX) stock has traded between a high of $3.22 and a low of $1.00.
People also own
Based on the portfolios of people who own ENTX. This list is generated using Robinhood data, and it’s not a recommendation.